Search Results 581-590 of 17547 for Menses

  1. Dose Escalation Study in Patients With Relapsed or Refractory DLBCL and MyD88 L265P Mutation - Mayo Clinic

    Recent reports have identified a specific oncogenic mutation L265P of the MYD88 gene in approximately 30% of the patients with the activated B-cell (ABC) type ...

  2. Mayo Clinic

    ... . IMG-20451552. Home; cc-tired-man-thumbnail. Fuel groundbreaking medical research! Give Today. Your donation powers the future of medicine and helps ...

  3. Polycystic ovary syndrome (PCOS) - Doctors and departments - Mayo Clinic

    Polycystic ovaries, hormone imbalance and irregular periods are telltale signs and symptoms of polycystic ovary syndrome. Find out about treatments.

  4. A Study to Evaluate Intravenous Ascorbic Acid (Vitamin C) as an Adjunct to Pazopanib in the First-Line or Post-immunotherapy Setting for Metastatic or Unresectable Clear Cell Renal Cell Carcinoma (ccRCC) - Mayo Clinic

    NOTE: Subjects not using hormone replacement therapy (HRT) must have experienced total cessation of menses for ≥ 1 year and be greater than 45 years in age ...

  5. A Study to Define Success After Artificial Urinary Sphincter Placement in Men from Patient Subjective and Objective Assessment - Mayo Clinic

    The purpose of this study is to define the successful placement of the Artificial Urinary Sphincter in Men, by collecting and comparing patient subjective and ...

  6. A Study to Better Understand and Improve the Conversations that Patients and Clinicians Have about Particular Types of Testing - Mayo Clinic

    The purpose of this study is to seek to understand the conversations that occur between clinicians and patients in clinical encounters when particular testing ...

  7. A Study to Evaluate Regorafenib with Cetuximab or Panitumumab to Treat Unresectable, Locally Advanced, or Metastatic Colorectal Cancer - Mayo Clinic

    Note: Post-menopausal women (defined as no menses for at least 1 year) and surgically sterilized women are not required to undergo a pregnancy test. The ...

  8. Mayo Clinic

    Share · Tweet . IMG-20312211. Home; 3120374-0003. Double your impact! Give Now! Your GivingTuesday gift can go 2X as far.

  9. A Study to Evaluate the Safety and Effectiveness of BMS-986036 (pegbelfermin) in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Fibrosis - Mayo Clinic

    About this study. The purpose of this study is to confirm and extend the results observed in the Phase 1 and 2a studies with BMS-986036.

  10. A Study of Everolimus with or without Bevacizumab for Treating Patients with Advanced Kidney Cancer that Progressed after First-Line Therapy - Mayo Clinic

    Everolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as bevacizumab, can interfere ...